BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.37
0.06%
After-hours: Aug 15, 2025, 07:46 PM EDT
BioCryst Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 32K | -26.8M | -14.03M | -12.67M | -35.38M | -61.73M | -36.15M | -75.33M | -53.33M | -71.54M | -42.52M | -58.86M | -74.2M | -17.78M | -58.8M | -43.2M | -64.28M |
Depreciation & Amortization | 331K | 309K | 311K | 320K | 306K | 423K | 420K | 407K | 405K | 396K | 389K | 335K | 317K | 171K | 229K | 199K | 178K |
Stock-Based Compensation | 21.37M | 21.34M | 17.25M | 13.17M | 13.65M | 16.49M | 12.28M | 12.84M | 14.01M | 15.28M | 9.95M | 9.87M | 9.6M | 8.5M | 13.03M | 7.63M | 5.48M |
Other Working Capital | -47.27M | 574K | -4.3M | 1.75M | 1.11M | 291K | -1.35M | 1.63M | -2.58M | -6.75M | 6.41M | 8.43M | -2.25M | 14.99M | 54K | 148K | -7.72M |
Other Non-Cash Items | 12.88M | 11.27M | 13.85M | 16.11M | 16.26M | 17.33M | 19.75M | 49.91M | 19.07M | 43.77M | 17.66M | 17.6M | 19.03M | 17.76M | 13.78M | 11.64M | 11.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 475K | -12.74M | n/a | n/a | n/a | n/a | n/a | n/a | -55.88M | 1K | 20K | 14K |
Change in Working Capital | -62.13M | -11.33M | -9.13M | -18.3M | -48.52M | 18.1M | -16.2M | -6.64M | -27.66M | -11.76M | -17.93M | 3.3M | -32.55M | 14.76M | 8.49M | -1.7M | -13.43M |
Operating Cash Flow | -27.52M | -5.21M | 8.24M | -1.37M | -53.68M | -8.92M | -19.9M | -18.81M | -47.51M | -23.85M | -32.44M | -27.76M | -77.8M | -32.46M | -23.28M | -25.41M | -61.01M |
Capital Expenditures | -143K | -675K | -59K | -155K | -235K | -554K | -987K | -467K | -160K | -526K | -175K | -244K | -406K | -1.11M | -365K | -813K | -99K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 5.38M | -24.11M | 18.57M | 160K | n/a | 69.37M | 97.19M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -48.76M | -39.53M | -26.93M | -112.29M | -88.01M | -156.99M | -123.89M | -84.89M | -148.64M | n/a | -105.02M | -101.19M | -38.07M | -10.01M | n/a | n/a | n/a |
Sales Maturities Of Investments | 76M | 58M | 35.48M | 110M | 117M | 129.07M | 148M | 66.33M | 41.69M | 77.74M | 35.66M | 4M | n/a | n/a | 8.11M | 5.32M | 14.77M |
Other Investing Acitivies | -143K | n/a | -449K | -2.29M | -235K | n/a | n/a | n/a | -160K | 77.74M | -69.37M | -97.19M | -38.07M | -10.01M | 8.11M | -1K | 1K |
Investing Cash Flow | 27.09M | 17.8M | 8.49M | -2.45M | 28.76M | -28.47M | 23.12M | -19.04M | -107.11M | 77.22M | -69.54M | -97.44M | -38.47M | -11.12M | 7.75M | 4.5M | 14.67M |
Debt Repayment | -516K | n/a | -556K | -402K | -390K | -1.17M | n/a | n/a | n/a | n/a | 73.07M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.04M | -3.44M | -261K | -1.58M | -669K | -2.01M | 1.21M | 29.15M | 5.08M | 4.2M | 3.25M | 147K | 7.36M | 297.42M | 4.78M | 4.57M | 2.9M |
Financial Cash Flow | 529K | -4.02M | 1.27M | -1.97M | -1.05M | -3.17M | 1.23M | 29.36M | 5.08M | 4.2M | 76.33M | 147K | 7.36M | 347.42M | 4.78M | 4.57M | 2.9M |
Net Cash Flow | 558K | 7.26M | 18.86M | -5.93M | -26.32M | -40.04M | 4.7M | -8.81M | -149.64M | 57.9M | -25.68M | -124.84M | -108.88M | 303.84M | -10.77M | -16.25M | -43.44M |
Free Cash Flow | -27.66M | -5.89M | 8.19M | -1.93M | -53.92M | -9.47M | -20.88M | -19.28M | -47.67M | -24.38M | -32.62M | -28M | -78.21M | -33.57M | -23.64M | -26.22M | -61.11M |